TriVirix Ended 2006 Successful and Is Excited About the Upcoming Year
TriVirix, a contract manufacturer of biotech devices located in Milaca Minnesota, is pleased to announce that 2006 was a successful and pivotal year for the organization. Financially, TriVirix posted a profit for 2006 while consolidating capabilities and customers in its Milaca Minnesota operations. Furthermore, due to positive growth, TriVirix has scheduled a 35,000 square foot expansion for its Minnesota facility slated for 2007 that will enhance TriVirix' ISO 13485/FDA registered operations and allow for future growth. To support this growth, TriVirix has also secured a strategic two million dollar line of credit with its banking partner, Silicon Valley Bank, who has been critical to TriVirix success. Paul Fink, President and CEO of TriVirix stated, "2007 will be a very exciting year for us. Not only are we focused on growing our customer base and revenues, but we are also focused on optimizing our processes to better support our customer's needs".
TriVirix is a contract manufacturer that builds complex electro-mechanical systems and devices for the medical, analytical, diagnostic and life-science industries. TriVirix invests in manufacturing infrastructure so its customers can manage a single part number and remain focused on their core technologies and strengths.